Interstitial Lung Disease Trial, Recruiting NCT05189496 Sponsor: Guangdong Provincial People's Hospital Condition: Interstitial Lung Disease
Back to Interstitial Lung Disease

Interstitial Lung Disease Trial, Recruiting

NCT05189496
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing to participate and sign a written consent form
  • People who have previously been diagnosed with breast cancer (confirmed by laboratory tissue testing) and received full surgical treatment, followed by chemotherapy and then radiation therapy
  • People whose breast cancer has not spread to distant parts of the body, and who do not have cancer that has returned only in the neck lymph nodes
  • People who do not have a second, unrelated cancer in another part of the body
  • People aged 18 to 70 years old (men and women are both eligible)
  • People whose general physical functioning is rated as fully active or restricted only in strenuous activity (a score of 0 or 1 on a standard medical scale called the ECOG scale — confirm with trial site if unsure)
  • People whose doctors expect them to live for at least 2 more years
  • People whose chest scans (CT scans) taken before and after radiation therapy showed no signs of acute radiation-related lung injury

Who may not be able to join:

  • People with certain lung conditions, including severe chronic breathing problems, large air pockets in the lungs (bullous lung disease), active or ongoing lung infections, poorly controlled asthma, or an untreated collapsed lung — these are considered safety concerns for the oxygen treatment used in this trial
  • People with a history of ear surgery, middle ear problems (such as issues with the tube connecting the ear and throat, or recurring dizziness), or certain eye conditions such as retinal detachment
  • People who have previously received hyperbaric oxygen therapy (a treatment involving breathing pure oxygen in a pressurised chamber)
  • People who had radiation-related lung inflammation (radiation pneumonia) at the time of joining or before the study treatment begins
  • Women who are pregnant or breastfeeding
  • People who did not complete their full breast cancer treatment — for example, due to their disease getting worse, side effects they could not tolerate, or choosing to stop treatment
  • People who require a machine to help them breathe
  • People who are unable to follow or understand simple instructions
  • People who are confused about where they are or when they are, or who have a diagnosed mental health disorder

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13922118086

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Guangdong Provincial People's Hospital
Registry
ClinicalTrials.gov
Start date
1 March 2022
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence of radiation pneumonitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov